Phosphorus-vanadium mixed doped TiO2 / montmorillonite composite catalyst as well as preparation method and application thereof
Through the preparation of the phosphorus and vanadium mixed doping TiO2/montmorillonite composite catalyst, the problem of insufficient photocatalyst activity and difficulty in removing antibiotics is solved, and the efficient degradation of antibiotics is achieved, ensuring the environmental and human health and safety.
Patent Information
- Application Number
- CN202410990652.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-23
- Publication Date
- 2024-11-12
AI Technical Summary
Existing photocatalysts have insufficient catalytic activity when treating difficult biodegradable organic pollutants in industrial wastewater, and antibiotics are difficult to completely remove in the environment, resulting in environmental pollution and human health threats.
The phosphate and vanadium mixed doped TiO2/montmorillonite composite catalyst is used to mix the phosphate, vanadium salt and titanium sulfate solution through the preparation method, adjust the pH value and carry out hydrothermal reaction to form a composite catalyst with high catalytic activity.
This catalyst significantly improves the degradation rate of levofloxacin and ciprofloxacin antibiotics, has good visible photocatalytic activity and stability, can be reused, and effectively reduces the residual antibiotics in the environment.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of catalysts, and in particular to a phosphorus-vanadium mixed doped TiO2 / montmorillonite composite catalyst, a preparation method and application thereof. Background Art
[0002] At present, antibiotics are one of the most widely used and used drugs in the world. They rank third in the use of human medical drugs, accounting for more than 6% of the total prescription drugs, and more than 70% of the use of veterinary drugs. However, most antibiotic drugs cannot be completely metabolized in humans and animals, and are excreted from the body through feces in the form of prototypes and active metabolites. Antibiotic metabolites excreted from the body still have biological activity and can further form matrices in the environment. In recent years, studies have continuously found that environmental samples at home and abroad, such as soil, surface water, and sediment, have detected antibiotics at different concentrations. Groundwater, as the main source of drinking water in my country, has also been reported to detect antibiotics. These antibiotics in the environment may cause the resistance of sensitive bacteria in the environment to increase, and because the current water treatment technology cannot completely remove antibiotics in water, these antibiotics will eventually enter the human body through drinking water. Long-term accumulation may cause the human body to develop drug resistance and produce bacteria similar to super bacteria, which brings great pollution and harm to the environment and humans. Therefore, how to quickly and accurately detect the concentration of antibiotics in liquids and degrade the antibiotics in them has become a hot topic.
[0003] At present, people have realized that antibiotics left in the natural water environment will cause harm to the human body, but due to their wide range of existence and difficulty in biodegradation, there has been no efficient solution; some researchers are committed to the research and development of photocatalysts, but still face many challenges when treating difficult-to-biodegrade organic pollutants in industrial wastewater. How to further improve the catalytic activity of photocatalysts still requires research and exploration by researchers. Summary of the invention
[0004] In view of the deficiencies in the above-mentioned prior art, the present invention provides a phosphorus-vanadium mixed doped TiO2 / montmorillonite composite catalyst and a preparation method thereof. The prepared phosphorus-vanadium mixed doped TiO2 / montmorillonite composite catalyst has good photocatalytic activity.
[0005] In order to achieve the above object, the present invention provides a method for preparing a phosphorus-vanadium mixed doped TiO2 / montmorillonite composite catalyst, comprising the following steps:
[0006] Step 1: Weigh a certain amount of titanium sulfate into a clean beaker, weigh distilled water into the beaker, and prepare a titanium sulfate solution;
[0007] Step 2: preparing a phosphate solution and a vanadium salt solution, adding the obtained phosphate solution and vanadium salt solution to the titanium sulfate solution obtained in step 1, and stirring magnetically to fully dissolve the solution to obtain a mixed solution;
[0008] Step 3: slowly add sodium hydroxide solution to the mixed solution obtained in step 2 while stirring, and adjust the pH value of the solution to 1-3;
[0009] Step 4: Add a certain amount of montmorillonite to the solution obtained in step 3, and further slowly add sodium hydroxide solution to adjust the pH value to 2-5;
[0010] Step 5: The solution obtained in step 4 is subjected to magnetic stirring, and a hydrothermal reaction is carried out in a high-pressure reactor. The catalyst is centrifugally washed, dried and ground to obtain a phosphorus-vanadium mixed doped TiO2 / montmorillonite composite catalyst.
[0011] In some embodiments, the phosphate is selected from one or both of dihydrogen phosphate or orthophosphate.
[0012] In some embodiments, the vanadium salt is selected from one or both of vanadium nitrate and vanadium sulfate.
[0013] In some embodiments, the mass ratio of the phosphate to the titanium sulfate is 1:6-1:10.
[0014] In some of the embodiments, the mass ratio of the phosphate to the vanadium salt is 2:3-2:5.
[0015] In some embodiments, the montmorillonite in step 4 is soaked in water one day before use and ultrasonicated for one hour before use.
[0016] In some embodiments, the reaction time of the hydrothermal reaction in step 5 is 8-14 hours.
[0017] In some embodiments, the reaction temperature of the hydrothermal reaction in step 5 is 180-260°C.
[0018] The present invention also provides a phosphorus-vanadium mixed doped TiO2 / montmorillonite composite catalyst, which is prepared by the above-mentioned phosphorus-vanadium mixed doped TiO2 / montmorillonite composite catalyst preparation method.
[0019] The present invention also provides the use of the phosphorus-vanadium mixed doped TiO2 / montmorillonite composite catalyst in antibiotic degradation treatment.
[0020] Compared with the prior art, the present invention has the following advantages:
[0021] The phosphorus-vanadium mixed doped TiO2 / montmorillonite composite catalyst prepared by the present invention has good visible light catalytic activity, and the highly dispersed montmorillonite flakes play a good role in fixing and activating the phosphorus-vanadium doped TiO2. It has a good degradation effect on antibiotics such as levofloxacin and ciprofloxacin, and has high stability. The degradation ability will not be greatly reduced after multiple recycling, and it can be used as a stable catalyst for repeated use. DETAILED DESCRIPTION
[0022] The technical solution of the present invention is described in detail below in conjunction with specific embodiments to further understand the purpose, solution and effect of the present invention, but it is not intended to limit the scope of protection of the claims attached to the present invention.
[0023] Example 1
[0024] A method for preparing a phosphorus-vanadium mixed doped TiO2 / montmorillonite composite catalyst comprises the following steps:
[0025] Step 1: Weigh a certain amount of titanium sulfate into a clean beaker, weigh distilled water into the beaker, and prepare a titanium sulfate solution;
[0026] Step 2: preparing a phosphate solution and a vanadium salt solution, adding the obtained phosphate solution and vanadium salt solution to the titanium sulfate solution obtained in step 1, and stirring magnetically to fully dissolve the solution to obtain a mixed solution;
[0027] The phosphate salts are dihydrogen phosphate and orthophosphate; the vanadium salts are vanadium nitrate and vanadium sulfate; the mass ratio of the phosphate to the titanium sulfate is 1:8; the mass ratio of the phosphate to the vanadium salt is 1:2;
[0028] Step 3: slowly add sodium hydroxide solution to the mixed solution obtained in step 2 while stirring to adjust the pH value of the solution to 2;
[0029] Step 4: Soak the montmorillonite in water for one day, and then use the montmorillonite after ultrasonic treatment for one hour. Add a certain amount of the soaked montmorillonite wet material to the solution obtained in step 3, and then slowly add sodium hydroxide solution to adjust the pH value to 3;
[0030] Step 5: The solution obtained in step 4 is subjected to magnetic stirring, and a hydrothermal reaction is carried out in a high-pressure reactor for 8-14 hours at a hydrothermal reaction temperature of 180-260° C. Centrifugation, washing, drying and grinding are performed to obtain a phosphorus-vanadium mixed-doped TiO2 / montmorillonite composite catalyst.
[0031] Example 2
[0032] The only difference from Example 1 is that the mass ratio of the phosphate to the titanium sulfate is 1:6.
[0033] Example 3
[0034] The only difference from Example 1 is that the mass ratio of the phosphate to the titanium sulfate is 1:10.
[0035] Example 4
[0036] The difference from Example 1 is that the mass ratio of the phosphate to the vanadium salt is 2:3;
[0037] Example 5
[0038] The difference from Example 1 is that the mass ratio of the phosphate to the vanadium salt is 2:5;
[0039] Comparative Example 1
[0040] The only difference from Example 1 is that the phosphate salt is dihydrogen phosphate.
[0041] Comparative Example 2
[0042] The only difference from Example 1 is that the phosphate salt is orthophosphate.
[0043] Comparative Example 3
[0044] The difference from Example 1 is that the phosphate salt is hydrogen phosphate.
[0045] Comparative Example 4
[0046] The only difference from Example 1 is that the vanadium salt is vanadium chloride.
[0047] Comparative Example 5
[0048] The only difference from Example 1 is that the mass ratio of the phosphate to the titanium sulfate is 1:4.
[0049] Comparative Example 6
[0050] The only difference from Example 1 is that the mass ratio of the phosphate to the titanium sulfate is 1:12.
[0051] Comparative Example 7
[0052] The difference from Example 1 is that the mass ratio of the phosphate to the vanadium salt is 1:1.
[0053] Comparative Example 8
[0054] The difference from Example 1 is that the mass ratio of the phosphate to the vanadium salt is 2:7.
[0055] Performance Testing
[0056] The first step is to dilute the obtained medicine to prevent the antibiotic concentration from being too high and exceeding the instrument range. The absorption spectrum of the diluted antibiotic solution is measured by spectrophotometry. Then a small amount of antibiotic solution is taken, a certain amount of catalyst is added, and it is placed in a light box for photocatalysis. After photocatalysis, its absorption spectrum is measured by photometry. The change in absorbance before and after illumination is used to characterize the change in the concentration of the antibiotic in the solution, and further characterize the antibiotic degradation rate.
[0057] According to the principle of UV-visible spectrophotometer, the absorbance of a substance is proportional to the concentration of the substance in the solution, so the absorbance can be approximately regarded as the concentration. For a fixed characteristic peak, the change in its absorbance before and after illumination can represent the change in the concentration of the corresponding antibiotic before and after illumination, so the degradation rate of the antibiotic can be obtained by dividing the decrease in absorbance by the absorbance before illumination.
[0058] Degradation rate calculation formula:
[0059]
[0060] Where w represents the degradation rate, A0 represents the absorbance before the experiment, and A1 represents the absorbance after the experiment.
[0061] In the present invention, the absorbance of levofloxacin at 328nm after illumination is selected as a reference, and the absorbance of ciprofloxacin at 317nm after illumination is selected as a reference. Visible light is irradiated for 3h to obtain the following table data:
[0062] Table 1
[0063] Levofloxacin degradation rate Ciprofloxacin degradation rate Example 1 98% 97% Comparative Example 1 80% 79% Comparative Example 2 83% 77% Comparative Example 3 56% 69% Comparative Example 4 77% 75%
[0064] As can be seen from the above table, when the phosphate salt used in the preparation method of the phosphorus-vanadium mixed doped TiO2 / montmorillonite composite catalyst adopts dihydrogen phosphate and orthophosphate; when the vanadium salt adopts vanadium nitrate and vanadium sulfate, the degradation rate of levofloxacin reaches 98%, and the degradation rate of ciprofloxacin reaches 97%. Referring to Comparative Examples 1 and 2, when the phosphate salt adopts dihydrogen phosphate or the phosphate salt adopts orthophosphate, the degradation rate of levofloxacin and ciprofloxacin is significantly reduced; when the hydrogen phosphate in Comparative Example 3 is adopted, the degradation rate of levofloxacin is only 56%, and the degradation rate of ciprofloxacin is only 69%. When the vanadium salt adopts vanadium chloride, the degradation rate of levofloxacin and ciprofloxacin is also significantly reduced, proving that the catalyst prepared under the conditions of the preparation method of the phosphorus-vanadium mixed doped TiO2 / montmorillonite composite catalyst provided in the embodiment of the present invention has a good effect on the degradation rate of levofloxacin and ciprofloxacin.
[0065] Furthermore, after the composite catalyst prepared in Example 1 catalyzed the degradation of levofloxacin and ciprofloxacin, the solution was poured out, the catalyst was rinsed and dried, and then the degradation experiment was carried out again. After 5 cycles, the degradation rate of levofloxacin and ciprofloxacin could still reach more than 85%, indicating that the composite catalyst prepared by the embodiment of the present invention has good stability, thereby achieving the effect of saving resources.
[0066] Table 2
[0067] Levofloxacin degradation rate Ciprofloxacin degradation rate Example 1 98% 97% Example 2 96% 96% Example 3 97% 95% Comparative Example 5 88% 82% Comparative Example 6 87% 79%
[0068] As shown in Table 2, when the mass ratio of the phosphate to the titanium sulfate is 1:6-1:10, the prepared catalyst has a good degradation effect on levofloxacin and ciprofloxacin, up to 95%. Beyond this range, the degradation rate decreases.
[0069] Table 3
[0070]
[0071]
[0072] As shown in Table 3, when the mass ratio of the phosphate to the vanadium salt is 2:3-2:5, the prepared catalyst has a good degradation effect on levofloxacin and ciprofloxacin. When the mass ratio is beyond this range, the degradation rate is significantly reduced.
[0073] The above description is only a preferred embodiment of the present invention and does not limit the present invention in other forms. Any technician familiar with the profession may use the technical content disclosed above to change or modify it into an equivalent embodiment with equivalent changes and apply it to other fields. However, any simple modification, equivalent change and modification made to the above embodiment based on the technical essence of the present invention without departing from the content of the technical solution of the present invention still falls within the protection scope of the technical solution of the present invention.
Claims
1. A phosphorus-vanadium mixed doped TiO 2 / Preparation method of montmorillonite composite catalyst, Features: The steps include: Step 1: Weigh a certain amount of titanium sulfate into a clean beaker, weigh distilled water into the beaker, and prepare a titanium sulfate solution; Step 2: preparing a phosphate solution and a vanadium salt solution, adding the obtained phosphate solution and vanadium salt solution to the titanium sulfate solution obtained in step 1, and stirring magnetically to fully dissolve the solution to obtain a mixed solution; Step 3: slowly add sodium hydroxide solution to the mixed solution obtained in step 2 while stirring, and adjust the pH value of the solution to 1-3; Step 4: Add a certain amount of montmorillonite to the solution obtained in step 3, and further slowly add sodium hydroxide solution to adjust the pH value to 2-5; Step 5: The solution obtained in step 4 is subjected to magnetic stirring, subjected to hydrothermal reaction in a high-pressure reactor, centrifuged, washed, dried and ground to obtain phosphorus-vanadium mixed-doped TiO 2 / montmorillonite composite catalyst.
2. The phosphorus-vanadium mixed-doped TiO according to claim 1 2 / Preparation method of montmorillonite composite catalyst, Features: The phosphate is selected from one or both of dihydrogen phosphate and orthophosphate.
3. The phosphorus-vanadium mixed-doped TiO according to claim 1 2 / Preparation method of montmorillonite composite catalyst, Features: The vanadium salt is selected from one or both of vanadium nitrate and vanadium sulfate.
4. The phosphorus-vanadium mixed-doped TiO according to claim 1 2 / Preparation method of montmorillonite composite catalyst, Features: The mass ratio of the phosphate to the titanium sulfate is 1:6-1:
10.
5. The phosphorus-vanadium mixed-doped TiO according to claim 1 2 / Preparation method of montmorillonite composite catalyst, Features: The mass ratio of the phosphate to the vanadium salt is 2:3-2:
5.
6. The phosphorus-vanadium mixed-doped TiO according to claim 1 2 / Preparation method of montmorillonite composite catalyst, Features: The montmorillonite in step 4 is soaked in water one day before use and ultrasonically dispersed for more than one hour before use.
7. The phosphorus-vanadium mixed-doped TiO according to claim 1 2 / Preparation method of montmorillonite composite catalyst, Features: The reaction time of the hydrothermal reaction in step 5 is 8-14h.
8. The phosphorus-vanadium mixed-doped TiO according to claim 1 2 / Preparation method of montmorillonite composite catalyst, Features: The reaction temperature of the hydrothermal reaction in step 5 is 180-260°C.
9. A phosphorus-vanadium mixed doped TiO 2 / montmorillonite composite catalyst, Features: The phosphorus-vanadium mixed-doped TiO 2 The catalyst is prepared by a method for preparing a composite catalyst of montmorillonite.
10. The phosphorus-vanadium mixed-doped TiO according to claim 9 2 / montmorillonite composite catalyst can be used in antibiotic degradation treatment.
Citation Information
Patent Citations
Preparation method of vanadium-doped nano titanic oxide catalyst
CN101357329A
Low-temperature two-step method for preparing composite anatase type titanium dioxide visible light catalyst
CN102500426A
Bi2O3 / montmorillonite composite photocatalytic material and preparation method thereof
CN110560035A
Visible light responding type titanium oxide composite photocatalyst and its manufacturing method
JP2005138008A
